- Home
- PMCB vs AIHS Comparison
PMCB vs AIHS Comparison
Compare PMCB & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- AIHS
- Stock Information
- Founded
- PMCB 1996
- AIHS 2014
- Country
- PMCB United States
- AIHS China
- Employees
- PMCB N/A
- AIHS N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- AIHS Finance: Consumer Services
- Sector
- PMCB Health Care
- AIHS Finance
- Exchange
- PMCB Nasdaq
- AIHS Nasdaq
- Market Cap
- PMCB 11.4M
- AIHS 9.5M
- IPO Year
- PMCB N/A
- AIHS 2018
- Fundamental
- Price
- PMCB $1.19
- AIHS $0.89
- Analyst Decision
- PMCB
- AIHS
- Analyst Count
- PMCB 0
- AIHS 0
- Target Price
- PMCB N/A
- AIHS N/A
- AVG Volume (30 Days)
- PMCB 17.9K
- AIHS 15.3K
- Earning Date
- PMCB 03-17-2025
- AIHS 02-14-2025
- Dividend Yield
- PMCB N/A
- AIHS N/A
- EPS Growth
- PMCB N/A
- AIHS N/A
- EPS
- PMCB 1.29
- AIHS N/A
- Revenue
- PMCB N/A
- AIHS $5,878,700.00
- Revenue This Year
- PMCB N/A
- AIHS N/A
- Revenue Next Year
- PMCB N/A
- AIHS N/A
- P/E Ratio
- PMCB $0.89
- AIHS N/A
- Revenue Growth
- PMCB N/A
- AIHS 12.21
- 52 Week Low
- PMCB $1.05
- AIHS $0.77
- 52 Week High
- PMCB $2.42
- AIHS $1.45
- Technical
- Relative Strength Index (RSI)
- PMCB 39.44
- AIHS 49.76
- Support Level
- PMCB $1.05
- AIHS $0.86
- Resistance Level
- PMCB $1.27
- AIHS $0.91
- Average True Range (ATR)
- PMCB 0.12
- AIHS 0.05
- MACD
- PMCB 0.00
- AIHS 0.00
- Stochastic Oscillator
- PMCB 37.21
- AIHS 35.94
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.